{
  "ticker": "LLY",
  "timestamp": "2025-12-01T09:42:59.218186",
  "analysis_date": "2024-10-08",
  "historical_mode": true,
  "summary": {
    "recommendations": {
      "technical": "BUY",
      "news": "HOLD",
      "fundamental": "SELL",
      "macro": "HOLD"
    },
    "valid_recommendations": {
      "technical": "BUY",
      "news": "HOLD",
      "fundamental": "SELL",
      "macro": "HOLD"
    },
    "confidence_levels": {
      "technical": "Medium",
      "news": "Medium",
      "fundamental": "Medium",
      "macro": "Low"
    },
    "bull_signal_count": 28,
    "bear_signal_count": 16,
    "bull_rec_count": 1,
    "bear_rec_count": 1,
    "hold_rec_count": 2,
    "undetermined_count": 0,
    "analyst_count": 4,
    "valid_analyst_count": 4,
    "net_sentiment": "NEUTRAL"
  },
  "analyst_summaries": {
    "technical": "TECHNICAL: Uptrend confirmed, RSI 14 \u2192 BUY (Medium)",
    "news": "NEWS: Bullish sentiment (0 articles) \u2192 HOLD (Medium)",
    "fundamental": "FUNDAMENTAL: Mixed fundamentals \u2192 SELL (Medium)",
    "macro": "MACRO: Mixed macro \u2192 HOLD (Low)"
  },
  "full_analyst_reports": {
    "technical": "[TECHNICAL] *** HISTORICAL MODE: Analyzing as of 2024-10-08 ***\n\n======================================================================\nTECHNICAL ANALYSIS: LLY\nAnalysis Period: 7 days\n*** HISTORICAL MODE: As of 2024-10-08 ***\nTimestamp: 2025-12-01 09:41:30\n======================================================================\n\n[TECHNICAL] Fetching 7-day price data for LLY...\n[TECHNICAL] \u2713 Historical: 52 days ending 2024-10-08\n[TECHNICAL]   Date range: 2024-07-26 to 2024-10-08\n[TECHNICAL] \u2713 Retrieved 52 days of data\n[TECHNICAL] Calculating technical indicators...\n[TECHNICAL] \u2713 Indicators calculated\n[TECHNICAL] Identifying support/resistance levels...\n[TECHNICAL] \u2713 Support: $851.04, Resistance: $933.83\n[TECHNICAL] Formatting technical summary...\n[TECHNICAL] Generating analysis with gpt-4o-mini...\n[TECHNICAL] \u274c LLM error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n[TECHNICAL] Creating fallback analysis...\n\n[TECHNICAL] \u2713 Analysis complete in 18.61s\n======================================================================\n\n## Technical Analysis\n*Generated using fallback analysis (LLM unavailable)*\n\n\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2024-10-08 \u26a0\ufe0f**\nAll data below is historical, ending on 2024-10-08.\nDo NOT reference any price movements or events after this date.\n\n# Technical Analysis Data for LLY\n\n**Analysis Period:** 7 days (Data: 52 days available)\n**Date:** 2024-10-08\n\n## Price Action\n- **Current Price:** $905.46\n- **Period Change:** +3.14%\n- **Day's Range:** $894.07 - $913.63\n- **Volume:** 2,200,000\n- **Volume Assessment:** Normal levels\n\n## Momentum Indicators\n- **RSI(14):** 53.6 \u2192 Neutral zone\n- **MACD:** -3.396 | Signal: -1.768 | Histogram: -1.628\n  \u2192 Bearish momentum \u26a0\ufe0f\n- **Stochastic:** %K=67.7, %D=50.5\n\n## Moving Average Analysis\n- **SMA_5:** $887.08 (Above \u2713)\n- **EMA_10:** $891.29 (Above \u2713)\n- **SMA_20:** $899.38 (Above \u2713)\n- **SMA_50:** $892.60 (Above \u2713)\n\n**Trend:** Strong uptrend (price above all MAs) \u2713\n\n## Volatility & Range\n- **Bollinger Bands:** $865.40 < $905.46 < $933.36\n  \u2192 Middle range (59% position)\n- **ATR:** $18.42 (2.03% of price)\n  \u2192 Normal volatility\n\n## Support & Resistance\n- **Key Resistance:** $933.83\n- **Secondary Resistance:** $931.36\n- **Key Support:** $851.04\n- **Secondary Support:** $867.69\n\n- **Distance to Resistance:** +3.1%\n- **Distance to Support:** +6.4%\n\n## Potential Trade Setup\n- **Setup Type:** LONG\n- **Entry:** $905.46\n- **Stop Loss:** $877.82 (Risk: $27.63)\n- **Target:** $933.83 (Reward: $28.37)\n- **Risk/Reward Ratio:** 1.03:1\n  \u2192 Acceptable risk/reward\n\n\n---\n\n## Automated Assessment\n\n**Signals Detected:** 2 bullish, 0 bearish\n**Reasoning:** Multiple bullish signals: Strong uptrend, Price above MAs\n\nRECOMMENDATION: BUY - Confidence: Medium\n\n",
    "news": "[NEWS] *** HISTORICAL MODE: Analyzing as of 2024-10-08 ***\n\n======================================================================\nNEWS & SENTIMENT ANALYSIS: LLY\n*** HISTORICAL MODE: As of 2024-10-08 ***\nPeriod: Last 7 days | Sources: ['yahoo', 'finnhub']\nTimestamp: 2025-12-01 09:41:51\n======================================================================\n\n[NEWS] \ud83d\udd27 Fetching Yahoo Finance news...\n[NEWS] \u26a0\ufe0f Yahoo Finance has limited historical news support\n[NEWS] \u2713 Yahoo Finance: 0 articles\n[NEWS] \ud83d\udd27 Fetching Finnhub news...\n[NEWS] Finnhub: Fetching news from 2024-10-01 to 2024-10-08\n[NEWS] \u26a0\ufe0f Finnhub: No news\n[NEWS] \ud83d\udccb No historical news found - compiling market research\n[NEWS] \u26a0\ufe0f Date 2024-10-08 is past LLM knowledge cutoff (2024-01-01)\n[NEWS] \u26a0\ufe0f Skipping LLM context to prevent hallucination\n[NEWS] Analyzing with gpt-4o-mini...\n[NEWS] \u2713 Analysis complete (1139 chars)\n\n[NEWS] \u2713 Analysis complete in 23.45s\n======================================================================\n\n# News & Sentiment Analysis: LLY\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2024-10-08 \u26a0\ufe0f**\n**Analysis Period:** Last 7 Days\n**Date:** 2025-12-01 09:41\n\n======================================================================\n\n## Yahoo Finance News (7 Days before 2024-10-08)\n\nNo news found in the specified period\n(Historical mode: news before 2024-10-08)\n## Finnhub News (2024-10-01 to 2024-10-08)\n\nNo news found\n\n## Market Research Notes\n\n    **Note:** No news articles were found for this historical period, and the analysis date (2024-10-08) is beyond the AI's knowledge cutoff date. Unable to provide historical context without risk of inaccuracy.\n\n    For dates after January 2024, please rely on actual news sources or archived data.\n\n    \n======================================================================\n\n## News & Sentiment Summary\nThe lack of news coverage over the past week for Eli Lilly (LLY) indicates an absence of significant catalysts or events that could impact market sentiment or trading decisions. This scarcity of information suggests a stable environment, but it also raises concerns about potential market indifference or an ongoing lack of investor interest.\n\n## Key Headlines\n- No significant news reported in the past week.\n- Historical context suggests the potential for market stagnation without fresh catalysts.\n\n## Sentiment Assessment\n- **Overall Sentiment:** Neutral\n- **Sentiment Trend:** Stable\n- **News Volume:** Low\n\n## Catalysts Identified\n**Bullish Catalysts:** None identified.\n**Bearish Catalysts:** None identified.\n**Upcoming Events:** None mentioned.\n\n## Trading Implications\nGiven the absence of recent news and catalysts, trading decisions should be approached with caution. The neutral sentiment and low news volume indicate that any position taken may rely heavily on broader market trends or the potential for future developments rather than immediate events. \n\nRECOMMENDATION: HOLD - Confidence: Medium\n",
    "fundamental": "[FUNDAMENTALS] *** HISTORICAL MODE: Analyzing as of 2024-10-08 ***\n\n======================================================================\nFUNDAMENTAL ANALYSIS: LLY\n*** HISTORICAL MODE: As of 2024-10-08 ***\nTimestamp: 2025-12-01 09:42:17\n======================================================================\n\n[FUNDAMENTALS] Fetching comprehensive data for LLY...\n[FUNDAMENTALS] \u2713 Comprehensive data retrieved\n[FUNDAMENTALS] Calculating historical metrics for 2024-10-08...\n[FUNDAMENTALS] \u2713 Historical metrics calculated: 4\n[FUNDAMENTALS]   - Price: $905.46\n[FUNDAMENTALS]   - P/E: 835.21\n[FUNDAMENTALS]   - P/B: 56.91\n[FUNDAMENTALS]   - Current Ratio: 1.27\n[FUNDAMENTALS] Analyzing earnings history...\n[FUNDAMENTALS] Filtering earnings to before 2024-10-08\n[FUNDAMENTALS] \u2713 Earnings analysis complete (3/4 beats)\n[FUNDAMENTALS] Fetching SEC 10-K filing data...\n[FUNDAMENTALS] Generating analysis with gpt-4o-mini...\n[FUNDAMENTALS] \u2713 Analysis generated (3184 chars)\n\n[FUNDAMENTALS] \u2713 Analysis complete in 16.68s\n======================================================================\n\n## Fundamental Analysis Summary\n**Overall Assessment:** Eli Lilly and Company exhibits extraordinary earnings growth and robust profitability metrics; however, its extremely high P/E and Price/Book ratios suggest significant overvaluation compared to historical norms.\n\n## Key Findings\n### Valuation\n- **Trailing P/E Ratio:** At 835.21, Eli Lilly's trailing P/E is exceptionally high, indicating that the stock may be overpriced relative to its earnings.\n- **Price/Book Ratio:** The Price/Book ratio stands at 56.91, far exceeding typical values for the healthcare sector, which often ranges from 3 to 5. This points to a potential premium pricing that's not justified by the underlying asset value.\n- **EV/Revenue and EV/EBITDA:** Both ratios (16.76 for EV/Revenue and 34.66 for EV/EBITDA) are also elevated, further suggesting a premium valuation.\n\n### Growth & Profitability  \n- **Revenue Growth:** Eli Lilly's revenue growth at 53.9% is impressive, reflecting strong demand and successful product offerings.\n- **Earnings Growth:** An astonishing earnings growth of 480.4% indicates exceptional operational performance, likely driven by new drug approvals or market expansions.\n- **Margins:** Profit margin at 31.0%, operating margin at 48.3%, and gross margin at 83.0% all suggest a highly profitable business model, further reinforcing the company's strong market position.\n\n### Financial Health\n- **Current Ratio:** At 1.27, the current ratio is slightly below the healthy threshold of 1.5, indicating potential liquidity concerns but not critical.\n- **Debt/Equity Ratio:** A high Debt/Equity ratio of 178.52 indicates significant leverage, which could pose risks if economic conditions worsen or if the company struggles to generate cash flow.\n- **Free Cash Flow:** Positive at $1.40B, indicating the ability to fund operations and investments, although growth in free cash flow should be monitored.\n\n### Earnings Quality\n- **Earnings Beat/Miss Pattern:** Eli Lilly has a beat rate of 75%, with three beats and one miss over the last four quarters, indicating strong earnings quality. However, the trend in earnings surprises is declining, which could be a red flag for future performance.\n\n## Investment Thesis\n**Bull Case:**\n1. Exceptional earnings growth of 480.4% suggests strong operational leverage and market leadership.\n2. High profit margins indicate a solid operational foundation and effective cost management.\n3. Positive free cash flow demonstrates financial flexibility and capacity for future investments or dividends.\n\n**Bear Case:**\n1. Extremely high valuation metrics (P/E and Price/Book) raise concerns about sustainability and potential price corrections.\n2. High Debt/Equity ratio presents risks associated with leverage, particularly in a rising interest rate environment.\n3. Declining trend in earnings surprises could indicate challenges in maintaining growth momentum.\n\n## Final Recommendation\nRECOMMENDATION: SELL - Confidence: Medium\n**Risk Level:** High\n\nGiven the high valuation metrics and potential risks associated with debt and declining earnings surprise trends, investors may want to reconsider holding this stock at its current price levels.\n",
    "macro": "[MACRO] *** HISTORICAL MODE: Analyzing as of 2024-10-08 ***\n\n======================================================================\nMACRO ECONOMIC ANALYSIS\nPeriod: 7 days | Sector: All\n*** HISTORICAL MODE: As of 2024-10-08 ***\nTimestamp: 2025-12-01 09:42:36\n======================================================================\n\n[MACRO] Starting iterative analysis...\n[MACRO] Iteration 1/10\n[MACRO] \ud83d\udd27 Executing: get_market_indicators\n[MACRO] \ud83d\udd27 Tool: get_market_indicators (days=7)\n[MACRO] \u2713 Fetched 6/6 indicators\n[MACRO] \ud83d\udd27 Executing: get_sector_performance\n[MACRO] \ud83d\udd27 Tool: get_sector_performance (days=7)\n[MACRO] \u2713 Analyzed 9/9 sectors\n[MACRO] \ud83d\udd27 Executing: get_economic_indicators\n[MACRO] \ud83d\udd27 Tool: get_economic_indicators (days=7)\n[MACRO] \u2713 Economic indicators retrieved\n[MACRO] \ud83d\udd27 Executing: get_market_breadth\n[MACRO] \ud83d\udd27 Tool: get_market_breadth (days=7)\n[MACRO] \u2713 Breadth analysis complete\n[MACRO] Iteration 2/10\n[MACRO] \u274c Error in iterative analysis: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}\n\n[MACRO] \u2713 Complete in 22.74s\n======================================================================\n\n# Macro Analysis (Partial)\n*Analysis Period: 7 days*\n**\u26a0\ufe0f HISTORICAL ANALYSIS AS OF 2024-10-08**\n*Successful Tools: 4, Failed: 0*\n\nRaw data gathered successfully:\n\nTools executed: get_market_indicators, get_sector_performance, get_economic_indicators, get_market_breadth\n\nRECOMMENDATION: NEUTRAL - Confidence: Low (Partial data)\n\n"
  },
  "bull_evidence": [
    {
      "source": "technical",
      "signal": "**Reasoning:** Multiple bullish signals: Strong uptrend, Price above MAs",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "technical",
      "signal": "[TECHNICAL] \u2713 Support: $851",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "## Momentum Indicators",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "**Trend:** Strong uptrend (price above all MAs) \u2713",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Key Support:** $851",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Secondary Support:** $867",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Distance to Support:** +6",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "RECOMMENDATION: BUY - Confidence: Medium",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "[NEWS] \u26a0\ufe0f Yahoo Finance has limited historical news support",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Bullish Catalysts:** None identified",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "- **Earnings Beat/Miss Pattern:** Eli Lilly has a beat rate of 75%, with three beats and one miss over the last four quarters, indicating strong earnings quality",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "fundamental",
      "signal": "Declining trend in earnings surprises could indicate challenges in maintaining growth momentum",
      "strength": 2,
      "keywords_matched": 2
    },
    {
      "source": "fundamental",
      "signal": "[FUNDAMENTALS] \u2713 Earnings analysis complete (3/4 beats)",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "**Overall Assessment:** Eli Lilly and Company exhibits extraordinary earnings growth and robust profitability metrics; however, its extremely high P/E and Price/Book ratios suggest significant overvaluation compared to historical norms",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "91, far exceeding typical values for the healthcare sector, which often ranges from 3 to 5",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "### Growth & Profitability",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "- **Revenue Growth:** Eli Lilly's revenue growth at 53",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "9% is impressive, reflecting strong demand and successful product offerings",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "- **Earnings Growth:** An astonishing earnings growth of 480",
      "strength": 1,
      "keywords_matched": 1
    }
  ],
  "bear_evidence": [
    {
      "source": "technical",
      "signal": "04, Resistance: $933",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Key Resistance:** $933",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Secondary Resistance:** $931",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Distance to Resistance:** +3",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "- **Risk/Reward Ratio:** 1",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "technical",
      "signal": "\u2192 Acceptable risk/reward",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "Unable to provide historical context without risk of inaccuracy",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "This scarcity of information suggests a stable environment, but it also raises concerns about potential market indifference or an ongoing lack of investor interest",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "news",
      "signal": "**Bearish Catalysts:** None identified",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "5, indicating potential liquidity concerns but not critical",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "52 indicates significant leverage, which could pose risks if economic conditions worsen or if the company struggles to generate cash flow",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "Extremely high valuation metrics (P/E and Price/Book) raise concerns about sustainability and potential price corrections",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "High Debt/Equity ratio presents risks associated with leverage, particularly in a rising interest rate environment",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "RECOMMENDATION: SELL - Confidence: Medium",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "**Risk Level:** High",
      "strength": 1,
      "keywords_matched": 1
    },
    {
      "source": "fundamental",
      "signal": "Given the high valuation metrics and potential risks associated with debt and declining earnings surprise trends, investors may want to reconsider holding this stock at its current price levels",
      "strength": 1,
      "keywords_matched": 1
    }
  ],
  "key_conflicts": [
    {
      "type": "recommendation_conflict",
      "severity": "CRITICAL",
      "analysts": [
        "fundamental",
        "technical"
      ],
      "positions": {
        "fundamental": "SELL",
        "technical": "BUY"
      },
      "description": "fundamental says SELL while technical says BUY"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "news",
        "technical"
      ],
      "positions": {
        "news": "HOLD",
        "technical": "BUY"
      },
      "description": "news says HOLD while technical says BUY"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "fundamental",
        "news"
      ],
      "positions": {
        "fundamental": "SELL",
        "news": "HOLD"
      },
      "description": "fundamental says SELL while news says HOLD"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "fundamental",
        "macro"
      ],
      "positions": {
        "fundamental": "SELL",
        "macro": "HOLD"
      },
      "description": "fundamental says SELL while macro says HOLD"
    },
    {
      "type": "recommendation_conflict",
      "severity": "MINOR",
      "analysts": [
        "macro",
        "technical"
      ],
      "positions": {
        "macro": "HOLD",
        "technical": "BUY"
      },
      "description": "macro says HOLD while technical says BUY"
    }
  ],
  "consensus_points": [
    {
      "type": "partial_consensus",
      "recommendation": "HOLD",
      "count": 2,
      "analysts": [
        "news",
        "macro"
      ],
      "description": "Partial consensus: news and macro both say HOLD"
    }
  ],
  "research_priorities": [
    {
      "priority": "CRITICAL",
      "focus": "resolve_major_conflict",
      "description": "BUY vs SELL conflict - fundamental says SELL while technical says BUY",
      "action": "Deep dive needed to determine which analyst is correct"
    },
    {
      "priority": "URGENT",
      "focus": "time_sensitive_event",
      "description": "Upcoming catalyst detected",
      "signal": "- **Earnings Beat/Miss Pattern:** Eli Lilly has a beat rate of 75%, with three beats and one miss over the last four quarters, indicating strong earnings quality",
      "source": "fundamental",
      "action": "Research before event occurs"
    }
  ],
  "analyst_reports_summary": {
    "technical": {
      "recommendation": "BUY",
      "confidence": "Medium",
      "report_length": 3028,
      "has_data": true,
      "completed_successfully": true
    },
    "news": {
      "recommendation": "HOLD",
      "confidence": "Medium",
      "report_length": 2934,
      "has_data": true,
      "completed_successfully": true
    },
    "fundamental": {
      "recommendation": "SELL",
      "confidence": "Medium",
      "report_length": 4269,
      "has_data": true,
      "completed_successfully": true
    },
    "macro": {
      "recommendation": "HOLD",
      "confidence": "Low",
      "report_length": 1737,
      "has_data": true,
      "completed_successfully": true
    }
  },
  "data_quality": {
    "status": "COMPLETE",
    "total_analysts": 4,
    "valid_analysts": 4,
    "failed_analysts": 0,
    "failed_list": [],
    "note": null
  },
  "llm_synthesis": "Synthesis error: Error code: 429 - {'error': {'message': 'Rate limit reached for gpt-4o-mini in organization org-KtddXWX7pT8yz52FN9uLjN7j on requests per day (RPD): Limit 10000, Used 10000, Requested 1. Please try again in 8.64s. Visit https://platform.openai.com/account/rate-limits to learn more.', 'type': 'requests', 'param': None, 'code': 'rate_limit_exceeded'}}",
  "synthesis_direction": "UNDETERMINED",
  "synthesis_confidence": "N/A"
}